Literature DB >> 8200848

Correlation between tumorigenicity and expression levels or splicing patterns of transcripts of the human papillomavirus type 16 E6 gene.

T Inoue1, S Kyo, T Kiyono, M Ishibashi, H Ishiwatari, Y I Hwang, M Yutsudo, A Hakura.   

Abstract

For determination of the correlation between tumorigenicity and the expression levels or splicing patterns of E6 mRNAs of the human papillomavirus type 16 in established cells, a vector containing the intact E6 open reading frame which expresses both unspliced and spliced mRNAs, one expressing only unspliced E6 mRNA, and one expressing both unspliced and spliced mRNAs but producing only truncated E6 proteins were constructed. In transformation assays and analyses of E6 mRNAs, a higher expression level of unspliced E6 mRNA was found to be closely associated with tumorigenicity. Furthermore, it was also related with anchorage-independent growth and a decreased serum requirement of the cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200848      PMCID: PMC5919467          DOI: 10.1111/j.1349-7006.1994.tb02367.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  33 in total

1.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

Authors:  K Münger; W C Phelps; V Bubb; P M Howley; R Schlegel
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

2.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

3.  Association of human papillomavirus types 16 and 18 E6 proteins with p53.

Authors:  B A Werness; A J Levine; P M Howley
Journal:  Science       Date:  1990-04-06       Impact factor: 47.728

4.  Co-localization of the tumor-suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines.

Authors:  X H Liang; M Volkmann; R Klein; B Herman; S J Lockett
Journal:  Oncogene       Date:  1993-10       Impact factor: 9.867

5.  Comparative study on E6 and E7 genes of some cutaneous and genital papillomaviruses of human origin for their ability to transform 3Y1 cells.

Authors:  A Hiraiwa; T Kiyono; K Segawa; K R Utsumi; M Ohashi; M Ishibashi
Journal:  Virology       Date:  1993-01       Impact factor: 3.616

6.  Identification of the human papillomavirus type 18 E6 and E6 proteins in nuclear protein fractions from human cervical carcinoma cells grown in the nude mouse or in vitro.

Authors:  A Schneider-Gädicke; S Kaul; E Schwarz; H Gausepohl; R Frank; G Bastert
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

7.  Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53.

Authors:  F Hoppe-Seyler; K Butz
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Transformation of rat 3Y1 cells by human papillomavirus type-18 DNA.

Authors:  S Watanabe; K Yoshiike
Journal:  Int J Cancer       Date:  1988-06-15       Impact factor: 7.396

9.  Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes.

Authors:  A Schneider-Gädicke; E Schwarz
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

10.  Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias.

Authors:  T Sasagawa; M Inoue; O Tanizawa; M Yutsudo; A Hakura
Journal:  Jpn J Cancer Res       Date:  1992-07
View more
  1 in total

1.  Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein.

Authors:  T Kiyono; A Hiraiwa; M Fujita; Y Hayashi; T Akiyama; M Ishibashi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.